16 May 2023
EuroPCR 2023 Hotlines/Late-Breaking clinical data: focus on left main and bifurcation PCI
Session comprising selected EuroPCR 2023 Late-Breaking Trial submissions
Summary
Listen to the presenters give you the latest information on left main and bifurcation from a series of late-breaking trials presented at EuroPCR 2023:
- The five-year follow-up of the EBC TWO 5-year follow-up study, which evaluated provisional versus culotte intervention for coronary bifurcations
- KISS: the benefit of side-branch intervention during provisional stenting in bifurcation lesions
- iFR-guided revascularization decision-making vs. FFR-guided revascularization decision-making in LM disease
- The impact of residual ischemia after LM bifurcation stenting on cardiovascular mortality
- A 3-year follow-up of the European Bifurcation Club left main coronary stent study
- A review of the dynamic coronary roadmap for contrast reduction trials
